NMC allows senior residency upto Age 50 in 8 depts, details The National Medical Commission (NMC) has specified that the ...

WORKPLACES nationwide are not equipped to deal with heatwaves and are putting workers at risk as extreme weather becomes more ...

Bayern Munich have made their ‘first offer’ for Liverpool winger Luis Diaz but it’s fallen miles short of the Reds’ valuation ...

Dr Ivan Williams Jimenez, senior policy and public affairs manager at the IOSH, said: “As heatwaves become more frequent and ...

The report is a novel effort to project measurable increases on costs for environmental cleanups that Jacksonville-area ...

Glenmark Pharmaceuticals’ stock surged 10% after signing a $2 billion deal with AbbVie to commercialize its cancer and autoimmune drug, hitting a 52-week high.

The stock surged 9.99 per cent to hit its 52-week high as well as the upper circuit limit of Rs 2,095.65 on the BSE.

Glenmark Pharma shares hit upper circuit limit after signing a USD 2 billion deal with AbbVie for a cancer drug. Stock hits ...

Shares of Nita Spaces surged 10%, hitting the upper circuit limit during Thursday's trading session, following the approval ...

FDA researchers report that the upper end of reported consumer use (~400mg of daily CBD intake) of cannabidiol (CBD) may ...

The Best and Worst Chest Exercises, According to a Trainer originally appeared on Men's Fitness. Chest day is sacred. But if ...